These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25984995)
1. Delay discounting is greater among drug users seropositive for hepatitis C but not HIV. Martin E; Gonzalez R; Vassileva J; Bechara A Neuropsychology; 2015 Nov; 29(6):926-32. PubMed ID: 25984995 [TBL] [Abstract][Full Text] [Related]
2. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy. Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598 [TBL] [Abstract][Full Text] [Related]
3. The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology. Gowin J; Sloan ME; Swan JE; Momenan R; Ramchandani VA Psychopharmacology (Berl); 2019 Feb; 236(2):775-785. PubMed ID: 30456539 [TBL] [Abstract][Full Text] [Related]
4. Functional MRI and delay discounting in patients infected with hepatitis C. McCready H; Kohno M; Kolessar M; Dennis L; Kriz D; Luber H; Anderson R; Chang M; Sasaki A; Flora K; Vandenbark A; Mitchell SH; Loftis JM; Hoffman WF; Huckans M J Neurovirol; 2018 Dec; 24(6):738-751. PubMed ID: 30298201 [TBL] [Abstract][Full Text] [Related]
6. Delay discounting, treatment motivation and treatment retention among substance-dependent individuals attending an in inpatient detoxification program. Stevens L; Verdejo-García A; Roeyers H; Goudriaan AE; Vanderplasschen W J Subst Abuse Treat; 2015 Feb; 49():58-64. PubMed ID: 25245429 [TBL] [Abstract][Full Text] [Related]
7. Verbal and spatial working memory among drug-using HIV-infected men and women. Martin E; Keutmann MK; Fogel JS; Maki PM; Gonzalez R; Vassileva J; Rubin LH; Hardy D J Neurovirol; 2018 Aug; 24(4):488-497. PubMed ID: 29687402 [TBL] [Abstract][Full Text] [Related]
8. Cross sectional study of factors associated to self-reported blood-borne infections among drug users. Reyes-Urueña J; Brugal MT; Majo X; Domingo-Salvany A; Caylà JA BMC Public Health; 2015 Nov; 15():1122. PubMed ID: 26566634 [TBL] [Abstract][Full Text] [Related]
9. Willing to Work But Not to Wait: Individuals with Greater Alcohol Use Disorder Show Increased Delay Discounting Across Commodities and Less Effort Discounting for Alcohol. Phung QH; Snider SE; Tegge AN; Bickel WK Alcohol Clin Exp Res; 2019 May; 43(5):927-936. PubMed ID: 30817019 [TBL] [Abstract][Full Text] [Related]
10. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar. Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287 [TBL] [Abstract][Full Text] [Related]
11. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250 [TBL] [Abstract][Full Text] [Related]
12. A comparison of delay discounting among substance users with and without suicide attempt history. Liu RT; Vassileva J; Gonzalez R; Martin EM Psychol Addict Behav; 2012 Dec; 26(4):980-5. PubMed ID: 22369220 [TBL] [Abstract][Full Text] [Related]
13. The phenotype of recovery III: Delay discounting predicts abstinence self-efficacy among individuals in recovery from substance use disorders. Athamneh LN; DeHart WB; Pope D; Mellis AM; Snider SE; Kaplan BA; Bickel WK Psychol Addict Behav; 2019 May; 33(3):310-317. PubMed ID: 30896193 [TBL] [Abstract][Full Text] [Related]
14. Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. Huckans MS; Blackwell AD; Harms TA; Indest DW; Hauser P AIDS; 2005 Oct; 19 Suppl 3():S106-15. PubMed ID: 16251805 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Hosseini M; SeyedAlinaghi S; Kheirandish P; Esmaeli Javid G; Shirzad H; Karami N; Jahani M; Seyed Ahmadian M; Payvarmehr F; Mohraz M; Emadi Koochak H; McFarland W Arch Iran Med; 2010 Jul; 13(4):318-23. PubMed ID: 20597566 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of hepatitis C virus coinfection in a human immunodeficiency virus-infected population with lower reported rates of injection drug use. Burton MJ; Olivier J; Mena L Am J Med Sci; 2009 Jul; 338(1):54-6. PubMed ID: 19474656 [TBL] [Abstract][Full Text] [Related]
17. Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. Li M; Li R; Shen Z; Li C; Liang N; Peng Z; Huang W; He C; Zhong F; Tang X; Lan G BMC Public Health; 2017 Sep; 17(1):759. PubMed ID: 28962612 [TBL] [Abstract][Full Text] [Related]
18. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users. Elliott JC; Hasin DS; Stohl M; Des Jarlais DC AIDS Behav; 2016 Mar; 20(3):548-54. PubMed ID: 26080690 [TBL] [Abstract][Full Text] [Related]
19. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort. Cox J; Maurais E; Hu L; Moodie EE; Law S; Bozinoff N; Potter M; Rollet K; Hull M; Tyndall M; Cooper C; Gill J; Saeed S; Klein MB; Drug Alcohol Depend; 2014 Apr; 137():121-8. PubMed ID: 24559606 [TBL] [Abstract][Full Text] [Related]
20. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]